High temperature resistant reverse transcriptase mutants and use thereof
The present invention provides a high temperature resistant reverse transcriptase mutant and its use. In particular, the present invention constructs a reverse transcriptase (M-MLV) mutant library, and the mutants with improved thermostability and higher amplification efficiency are finally screened out by stepwise screening. Under high temperature conditions, the reverse transcription efficiency of the reverse transcriptase mutant of the present invention is greatly improved compared to the wild type.
1 . A reverse transcriptase mutant having mutation(s) at amino acid residue(s) selected from the group consisting of: 313, 446, and 583,
wherein the amino acid residues are numbered according to SEQ ID NO: 1, a wild-type murine leukemia virus reverse transcriptase (M-MLV), and
wherein a reverse transcription efficiency of the reverse transcriptase mutant is higher compared to the wild-type murine leukemia virus reverse transcriptase.
2 . The reverse transcriptase mutant of claim 1 , wherein the amino acid residue 446 is mutated to Cys, the amino acid residue 313 is mutated to Gln, and the amino acid residue 583 is mutated to Asn.
3 . The reverse transcriptase mutant of claim 1 , wherein
the reverse transcriptase mutant has mutations at the amino acid residues 583 and 446, wherein the amino acid residue 583 is mutated to Asn, and the amino acid residue 446 is mutated to Cys, or the reverse transcriptase mutant has mutations at the amino acid residues 313 and 446, wherein the amino acid residue 313 is mutated to Gln, and the amino acid residue 446 is mutated to Cys, or the reverse transcriptase mutant has mutations at the amino acid residues 313, 583 and 446, and wherein the amino acid residue 313 is mutated to Gln, the amino acid residue 583 is mutated to Asn, and the amino acid residue 446 is mutated to Cys.
4 . A method for RNA reverse transcription comprising:
providing an RNA-containing sample; and performing a reverse transcription reaction of the RNA-containing sample with the reverse transcriptase mutant of claim 1 .